
Biotech Business - January 22, 2025
South Korea to grant precision medicine patent to Diamyd Medical
The South Korean Patent Office will grant a patent protecting the use of insulin-based antigens for the treatment of autoimmune diabetes in patients with the HLA DR4-DQ8 genetic marker.

Intellectual Property - December 18, 2024
Q&A Orexo: Patent litigation
Orexo has recently entered a settlement agreement with Sun Pharmaceuticals Industries to resolve a patent litigation regarding the company's Zubsolv sublingual tablet for the treatment of opioid use disorder in the US. NLS asked Nikolaj Sørensen, CEO of Orexo, about the impact of this settlement and his thoughts on the patent litigation process and generic challenges.

Intellectual Property - December 16, 2024
Orexo resolves US patent litigation with Sun
Orexo has entered into a settlement agreement with Sun Pharmaceuticals Industries to resolve the patent litigation regarding Zubsolv (buprenorphine and naloxone) sublingual tablet (CIII), for the treatment of opioid use disorder in the US.

Intellectual Property - December 2, 2024
Sigrid Therapeutics secures US patent
The company has been granted a US patent for its SiPore platform technology.

Intellectual Property - November 27, 2024
Abera Bioscience receives EU patent approval
Abera Bioscience has received the final decision to approve its patent application “Display of heterologous molecules on bacterial cells and membrane vesicles” from the European Patent Office (EPO).

Intellectual Property - October 31, 2024
Mucocort receives additional patent approval in China
Mucocort has been granted a patent in China for its product/technology, which has previously been approved under the European Patent System (EPC).